By Elizabeth Lucas and Sydney Lupkin Every year, pharmaceutical companies contribute millions of dollars to U.S. senators and representatives as part of a multipronged effort to influence health care lawmaking and spending priorities. Use this tool to explore the sizable role drugmakers play in the campaign finance system, where many industries seek to influence Congress. Discover which lawmakers Read More…
By Emmarie Huetteman House Democratic leaders on Thursday unveiled an aggressive plan to lower drug prices through negotiations between federal health officials and the makers of some of the most expensive drugs. Speaker Nancy Pelosi ushered the proposal through months of closed-door meetings primarily with other Democrats and experts on drug pricing. But she and other Democratic leaders Read More…
By John Edmond OPINION ShareNon Affiliate journalist. Original article published on the https://www.canadianlawyermag.com/external-contributors/john-edmond In his Trudeau II Report, released last month, Conflict of Interest and Ethics Commissioner Mario Dion found the Prime Minister in conflict of interest, for his role in the SNC-Lavalin scandal. For this to have occurred, Trudeau must have used his position “to seek to Read More…
